Outcome of In Vitro Fertilization and Embryo Transfer in Infertile Women with Pelvic Tuberculosis.
- Author:
Jin Yeong KIM
1
;
Inn Soo KANG
Author Information
1. Department of Obstetrics and Gynecology, Samsung Cheil Hospital, Sungkyunkwan University School of Medicine. ikang6@users.unitel.co.kr
- Publication Type:In Vitro ; Original Article
- Keywords:
Pelvic tuberculosis;
Infertility;
IVF-ET;
Endometrial tuberculosis
- MeSH:
Biopsy;
Drug Therapy;
Embryo Transfer*;
Embryonic Structures*;
Endometritis;
Endometrium;
Female;
Fertilization in Vitro*;
Humans;
Hysteroscopy;
Infertility;
Oocytes;
Peritonitis;
Pregnancy;
Pregnancy Rate;
Prognosis;
Salpingitis;
Tuberculosis*
- From:Korean Journal of Fertility and Sterility
2002;29(4):287-294
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: Pelvic tuberculosis (TB) causes infertility despite of anti-TB chemotherapy and IVF-ET is effective treatment to achieve pregnancy. The aim of this study is to assess the outcomes of IVF-ET in pelvic TB, especially according to main Tb lesion, and to investigate the factors affecting the successful outcome. METHODS: A total of 135 IVF-ET cycles were performed in 54 patients with pelvic TB and the outcome was compared with that of control group with tubal factor not associated with TB in 301 cycles, 227 patients. Anti-TB chemotherapy was performed in the patients with pelvic TB. Pregnancy rate was compared according to main TB lesion as salpingitis, peritonitis, and endometritis. In the patients with endometrial TB, when complicated with uterine synechia, hysteroscopic lysis was done before IVF-ET and pregnancy rate was compared according to the presence of uterine synechia. RESULTS: There was no significant difference in peak E2 (2,790+/-280.1 vs 2,554+/-101.2, p>0.05), the number of retrieved oocytes (13.5+/-0.7 vs 12.5+/-0.4, p>0.05) and fertilized oocytes (7.7+/-0.5 vs 7.8+/-0.3, p>0.05) between patient and control group. Clinical pregnancy rate per transfer in pelvic TB group was 22.9% and showed no difference from that of control group (24.3%, p>0.05). Although it was not statistically significant, pregnancy rate in the endometrial Tb (18%) was lower than that in the salpingitis (28.5%) or peritonitis (26.5%) (p>0.05). In the endometrial TB with uterine synechia, pregnancy rate was significantly lower than that of the patients without synechia even after hysteroscopic lysis (9.7% vs 31.6%, p<0.05). CONCLUSION: IVF-ET after anti-TB chemotherapy is the most effective treatment to achieve pregnancy in infertile patients with pelvic TB. Because the presence of endometrial TB and resulting uterine synechia affects the outcome of IVF-ET, thorough evaluation for endometrium with endometrial biopsy and hysteroscopy is important to predict the prognosis of IVF-ET treatment.
